O-1602 is a novel GPR55 agonist, an atypical cannabinoid associated with the central nervous system and obesity, and is a candidate compound for the treatment of cystitis.O-1602 promotes hepatic steatosis through GPR55 and PI3 kinase / Akt / SREBP-1c signalling in mice.O-1602 induces, in a GPR3-independent manner, in Hep55B cells with elevated intracellular calcium.
Molecular Weight:
258.36
Purity:
99.85%
CAS Number:
[317321-41-8]
Formula:
C17H22O2
Target:
Calcium Channel|||Cannabinoid Receptor
T23097
* VAT and and shipping costs not included. Errors and price changes excepted